Jeffrey W. Kelly - Net Worth and Insider Trading
Jeffrey W. Kelly Net Worth
The estimated net worth of Jeffrey W. Kelly is at least $5,684 dollars as of 2025-04-15. Jeffrey W. Kelly is the Director of Proteostasis Therapeutics Inc and owns about 5,121 shares of Proteostasis Therapeutics Inc (PTI) stock worth over $5,684. Details can be seen in Jeffrey W. Kelly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey W. Kelly has not made any transactions after 2017-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey W. Kelly
Jeffrey W. Kelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey W. Kelly owns 3 companies in total, including Proteostasis Therapeutics Inc (PTI) , Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .
Click here to see the complete history of Jeffrey W. Kelly’s form 4 insider trades.
Insider Ownership Summary of Jeffrey W. Kelly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTI | Proteostasis Therapeutics Inc | 2020-06-29 | director |
| YMTX | Yumanity Therapeutics Inc | 2016-02-10 | director |
| KANT | Kineta Inc | 2016-02-10 | director |
Jeffrey W. Kelly Latest Holdings Summary
Jeffrey W. Kelly currently owns a total of 1 stock. Jeffrey W. Kelly owns 5,121 shares of Proteostasis Therapeutics Inc (PTI) as of December 18, 2017, with a value of $5,684.
Latest Holdings of Jeffrey W. Kelly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTI | Proteostasis Therapeutics Inc | 2017-12-18 | 5,121 | 1.11 | 5,684 |
Holding Weightings of Jeffrey W. Kelly
Jeffrey W. Kelly Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey W. Kelly has made a total of 0 transactions in Proteostasis Therapeutics Inc (PTI) over the past 5 years. The most-recent trade in Proteostasis Therapeutics Inc is the acquisition of 200 shares on December 18, 2017, which cost Jeffrey W. Kelly around $20,000.
Insider Trading History of Jeffrey W. Kelly
- 1
Jeffrey W. Kelly Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey W. Kelly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey W. Kelly is 63.09%. GuruFocus also compares Jeffrey W. Kelly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey W. Kelly within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey W. Kelly's insider trading performs compared to the benchmark.
Performance of Jeffrey W. Kelly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.92 |  | | | | |
| Relative Return to S&P 500(%) | -8.93 | | | | | |
Jeffrey W. Kelly Ownership Network
Ownership Network List of Jeffrey W. Kelly
Ownership Network Relation of Jeffrey W. Kelly
Jeffrey W. Kelly Owned Company Details
What does Proteostasis Therapeutics Inc do?
Who are the key executives at Proteostasis Therapeutics Inc?
Jeffrey W. Kelly is the director of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .
Proteostasis Therapeutics Inc (PTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Proteostasis Therapeutics Inc Insider Transactions
Jeffrey W. Kelly Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey W. Kelly. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeffrey W. Kelly's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
